菊福堂生物控股有限公司（08217）于2026年2月3日发布截至2026年1月31日的股份变动月报表。公司法定股本维持在500,000,000股，面值每股港币0.16元，注册股本总额为港币80,000,000元。报告期内已发行股份（不含库存股）数量仍为301,860,000股，未见新增发行或回购注销活动。
公司同时列示两项股份期权计划，第一项授予数量为10,698,480股，行使价为每股港币0.315元，第二项授予数量为9,144,000股，行使价为每股港币0.163元。公告未披露本月操作变动，期权余额保持不变。
截至1月底，公司已发行股份总数维持稳定。公告最后确认公司遵守香港联交所《上市规则》及相关法律规定。该公告由公司秘书谭美珠签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.